Introduction
============

Aortic aneurysm is a serious condition that results from an atherosclerotic aorta and is a leading cause of mortality in humans ([@b1-ijmm-39-05-1091]). Studies on the genetic basis of familial aortic aneurysm have centered on the relationship between the condition to systemic connective tissue disorders such as Marfan syndrome ([@b2-ijmm-39-05-1091]) and Ehlers-Danlos syndrome ([@b3-ijmm-39-05-1091]). Although the molecular mechanism underlying nonsyndromic aortic aneurysm is complex and has not been determined definitively, several risk factors, including age, arteriosclerosis, hypertension and inflammatory or autoimmune diseases that affect the aorta, have been identified clinically ([@b4-ijmm-39-05-1091],[@b5-ijmm-39-05-1091]). In addition to these conventional risk factors, recent studies have shown the importance of genetic factors in the development of sporadic aortic aneurysm by revealing a heritability of \~70% ([@b6-ijmm-39-05-1091]). Genome-wide association studies (GWASs) have uncovered several loci and genes that confer susceptibility to aortic aneurysm in European ancestry populations ([@b7-ijmm-39-05-1091]--[@b12-ijmm-39-05-1091]), but genetic variants that contribute to the development of this condition in Japanese individuals have not been identified definitively.

Genetic variants previously associated with aortic aneurysm typically have a minor allele frequency (MAF) of \>10% and a small individual effect size ([@b7-ijmm-39-05-1091]--[@b12-ijmm-39-05-1091]). Given that these common variants explain only a small fraction of disease heritability, low-frequency (MAF of 0.5--5%) or rare (MAF of \<0.5%) variants with a larger effect size may contribute to the genetic architecture of aortic aneurysm ([@b13-ijmm-39-05-1091]).

In the present study, we performed exome-wide association studies (EWASs) with the use of exome array-based genotyping methods to identify single nucleotide polymorphisms (SNPs) - in particular, low-frequency or rare coding variants with a moderate to large effect size - that confer susceptibility to aortic aneurysm in Japanese individuals. Given that most low-frequency or rare variants were not included in the arrays of previous GWASs, we used Illumina HumanExome-12 DNA Analysis BeadChip or Infinium Exome-24 BeadChip arrays, which provide coverage for functional SNPs including low-frequency or rare variants in entire exons.

Materials and methods
=====================

Study population
----------------

A total of 8,782 Japanese individuals (456 patients with aortic aneurysm, 8,326 controls) was examined. The subjects were recruited from individuals who visited outpatient clinics of or were admitted to participating hospitals (Gifu Prefectural Tajimi Hospital, Tajimi; Gifu Prefectural General Medical Center, Gifu; Japanese Red Cross Nagoya First Hospital, Nagoya; Inabe General Hospital, Inabe; Hirosaki University Hospital and Hirosaki Stroke and Rehabilitation Center, Hirosaki) either because they were experiencing various symptoms or for an annual health checkup between 2002 and 2014; from community-dwelling individuals recruited to a population-based cohort study in Inabe between 2010 and 2014 or in Tokyo or Kusatsu between 2011 and 2015; or from individuals who underwent autopsy at Tokyo Metropolitan Geriatric Hospital from 1995 to 2012.

True aortic aneurysm was defined as a permanent localized dilation of the aorta with a ≥50% increase in diameter relative to the expected normal size of the artery or with a diameter of \>5 cm ([@b14-ijmm-39-05-1091]). Dissecting aortic aneurysm was defined as separation of the aortic wall layers with resulting true and false lumens or as intramural hematoma ([@b15-ijmm-39-05-1091]). The subjects with aortic aneurysm (279 with true aneurysm and 181 with dissecting aneurysm (four had both conditions) were examined by chest and abdominal X-ray and echocardiography followed by contrast medium-enhanced computed tomography. Some subjects were also examined by aortic angiography. Individuals with Marfan syndrome, Ehlers-Danlos syndrome, bicuspid aortic valve disease, aortitis syndrome, connective tissue disorder, congenital malformations of the heart or vessels, pseudoaneurysm, or traumatic aneurysm were excluded from the study. The control individuals had no history of aortic, coronary, or peripheral arterial disease; ischemic or hemorrhagic stroke; intracranial aneurysm; or other atherosclerotic, thrombotic, embolic or hemorrhagic disorders. Autopsy cases without aortic aneurysm were excluded from controls.

The study protocol complied with the Declaration of Helsinki and was approved by the Committees on the Ethics of Human Research of Mie University Graduate School of Medicine, Hirosaki University Graduate School of Medicine, Tokyo Metropolitan Institute of Gerontology, and participating hospitals. Written informed consent was obtained from each participant or from families of the deceased subjects.

EWASs
-----

Venous blood (5 or 7 ml) was collected into tubes containing 50 mmol/l ethylenediaminetetraacetic acid (disodium salt), peripheral blood leukocytes were isolated, and genomic DNA was extracted from these cells either with the use of a DNA extraction kit (Genomix supplied by Talent, Trieste, Italy, or SMITEST EX-R&D supplied by Medical and Biological Laboratories, Nagoya, Japan) or by standard protocols based on phenol-chloroform extraction and spin columns. In autopsy cases, genomic DNA was extracted from kidneys. EWASs were performed for the 456 subjects with aortic aneurysm (or for the 279 subjects with true aneurysm or 181 subjects with dissecting aneurysm) and the 8,326 control subjects with the use of a HumanExome-12 v1.1 or v1.2 DNA Analysis BeadChip or an Infinium Exome-24 v1.0 BeadChip (Illumina, San Diego, CA, USA). These exome arrays include putative functional exonic variants selected from \>12,000 individual exome or whole-genome sequences. The exonic content consists of \~244,000 SNPs representing diverse populations, including European, African, Chinese and Hispanic individuals ([@b16-ijmm-39-05-1091]). SNPs contained in only one of the exome arrays (\~3.6%) were excluded from analysis. We performed quality control ([@b17-ijmm-39-05-1091]) as follows. i) Genotyping data with a call rate of \<97% were discarded, with the mean call rate for the remaining data being 99.9%. ii) Gender specification was checked for each sample, with samples for which the gender designation in the clinical records was inconsistent with genetic sex being discarded. iii) Duplicated samples and cryptic relatedness were checked by calculation of identity by descent; all pairs with DNA samples showing identity by descent of \>0.1875 were inspected and one sample from each pair was excluded. iv) The frequency of heterozygosity of SNPs was calculated for all samples, with those found to have extremely low or high heterozygosity (\>3 standard deviations from the mean) being discarded. v) SNPs in sex chromosomes or mitochondrial DNA were excluded from the analysis, as were nonpolymorphic SNPs or SNPs with a MAF of \<0.1%. vi) SNPs whose genotype distributions in control individuals deviated significantly (P\<0.001) from Hardy-Weinberg equilibrium were excluded. vii) The genotype data for each EWAS were examined for population stratification by principal components analysis ([@b18-ijmm-39-05-1091]), and population outliers were excluded from the analysis. A total of 41,432 SNPs passed quality control and was subjected to analysis.

Statistical analysis
--------------------

Quantitative data for characteristics of the study subjects were compared between patients with aortic aneurysm and control individuals with the unpaired Student\'s t test. Categorical data were compared between the two groups with Fisher\'s exact test. Allele frequencies were estimated by the gene counting method, and Fisher\'s exact test was applied to identify departure from Hardy-Weinberg equilibrium. Allele frequencies of SNPs were compared between patients with aortic aneurysm and control subjects with Fisher\'s exact test. Multivariable logistic regression analysis was performed with aortic aneurysm as a dependent variable and independent variables including age, gender (0, woman; 1, man), the prevalence of hypertension (0, no history of this condition; 1, positive history), and genotype of each SNP. Genotypes of SNPs were assessed according to dominant \[0, AA; 1, AB+BB (A, major allele; B, minor allele)\], recessive (0, AA+AB; 1, BB), and additive genetic models, and the P-value, odds ratio, and 95% confidence interval were calculated. Additive models comprised additive 1 (0, AA; 1, AB; 0, BB) and additive 2 (0, AA; 0, AB; 1, BB) models, which were analyzed simultaneously with a single statistical model. To compensate for multiple comparisons of genotypes with aortic aneurysm, we applied Bonferroni\'s correction for statistical significance of association. Given that 41,432 SNPs were finally examined, a P-value of \<1.21×10^−6^ (0.05/41,432) was considered statistically significant. A quantile-quantile plot for P-values of allele frequencies in the EWAS for aortic aneurysm is shown in [Fig. 1](#f1-ijmm-39-05-1091){ref-type="fig"}. The inflation factor (λ) was 1.57. P-values for other comparisons were similarly adjusted by Bonferroni\'s correction. Statistical tests were performed with JMP Genomics version 6.0 software (SAS Institute, Cary, NC, USA).

Results
=======

Characteristics of the subjects
-------------------------------

The characteristics of the subjects enrolled in the study are shown in [Table I](#tI-ijmm-39-05-1091){ref-type="table"}. Age, the frequency of males, and the prevalence of hypertension, diabetes mellitus, dyslipidemia, chronic kidney disease and hyperuricemia were significantly greater in patients with aortic aneurysm than in control individuals.

EWAS of aortic aneurysm
-----------------------

We examined the correlation of allele frequencies for 41,432 SNPs that passed quality control to aortic aneurysm using the Fisher\'s exact test. A Manhattan plot for the EWAS of aortic aneurysm is shown in [Fig. 2](#f2-ijmm-39-05-1091){ref-type="fig"}. After Bonferroni\'s correction, 59 SNPs were found to be significantly (P\<1.21×10^−6^) associated with aortic aneurysm ([Table II](#tII-ijmm-39-05-1091){ref-type="table"}). The genotype distributions of these SNPs were in Hardy-Weinberg equilibrium (P\>0.001) both among patients with aortic aneurysm and among the control individuals (data not shown).

Multivariable logistic regression analysis of the correlation of SNPs to aortic aneurysm
----------------------------------------------------------------------------------------

The relation of the 59 identified SNPs to aortic aneurysm was examined further by multivariable logistic regression analysis with adjustment for age, gender and the prevalence of hypertension. Although 8 SNPs were related (P\<0.05) to aortic aneurysm, no SNP was significantly \[P\<2.12×10^−4^ (0.05/236)\] associated with this condition ([Table III](#tIII-ijmm-39-05-1091){ref-type="table"}). We then examined the correlation of the 8 identified SNPs to true or dissecting aortic aneurysm separately. Five SNPs were related (P\<0.05) to true aortic aneurysm ([Table IV](#tIV-ijmm-39-05-1091){ref-type="table"}), among which rs1465567 \[T/C (W229R)\] of EGF-like, fibronectin type III, and laminin G domains gene (EGFLAM) was significantly \[P\<0.0016 (0.05/32)\] associated with this condition, with the minor C allele representing a risk factor. No SNP was found to be related to dissecting aortic aneurysm (data not shown).

EWASs of true or dissecting aortic aneurysm
-------------------------------------------

We next examined the relation of allele frequencies for the total of 41,432 SNPs to true or dissecting aortic aneurysm separately with the use of Fisher\'s exact test. After Bonferroni\'s correction, 45 or 19 SNPs were found to be significantly (P\<1.21×10^−6^) associated with true ([Table V](#tV-ijmm-39-05-1091){ref-type="table"}) or dissecting ([Table VI](#tVI-ijmm-39-05-1091){ref-type="table"}) aortic aneurysm, respectively. The genotype distributions of these SNPs were in Hardy-Weinberg equilibrium (P\>0.001) both among patients with true or dissecting aortic aneurysm and among control individuals (data not shown).

Multivariable logistic regression analysis of the correlation of SNPs to true or dissecting aortic aneurysm
-----------------------------------------------------------------------------------------------------------

The corrrelation of the 45 identified SNPs to true aortic aneurysm was examined further by multivariable logistic regression analysis with adjustment for age, gender and the prevalence of hypertension. Among these SNPs, rs113710653 \[C/T (E231K)\] of the spermatogenesis and centriole-associated 1-like gene (*SPATC1L*) was significantly \[P\<2.78×10^−4^ (0.05/180)\] associated with true aortic aneurysm, with the minor T allele representing a risk factor for this condition ([Table VII](#tVII-ijmm-39-05-1091){ref-type="table"}). The correlation of the 19 identified SNPs to dissecting aortic aneurysm was also further examined by multivariable logistic regression analysis with adjustment for age, gender and the prevalence of hypertension. The SNP rs143881017 \[C/T (R140H)\] of the ribonuclease A family member 13 gene (RNASE13) was significantly \[P\<6.58×10^−4^ (0.05/76)\] associated with dissecting aortic aneurysm, with the minor T allele representing a risk factor for this condition ([Table VII](#tVII-ijmm-39-05-1091){ref-type="table"}).

Correlation of SNPs to intermediate phenotypes of aortic aneurysm
-----------------------------------------------------------------

Finally, we examined the correlation of three SNPs (rs1465567, rs113710653 and rs143881017) to intermediate phenotypes (hypertension, diabetes mellitus, hypertriglyceridemia, hypo-HDL-cholesterolemia, hyper-LDL-cholesterolemia, chronic kidney disease, obesity and hyperuricemia) of aortic aneurysm. No SNP was found to be significantly \[P\<0.0021 (0.05/24)\] associated with intermediate phenotypes (data not shown).

Discussion
==========

True and dissecting aneurysms of the aorta develop as a result of progressive weakening of the vessel wall. They are associated with characteristic histological features including medial degeneration, which involves degeneration and fragmentation of elastic fibers as well as loss of smooth muscle cells and an accumulation of basophilic ground substances ([@b19-ijmm-39-05-1091]). In the present study, we showed that rs1465567 \[T/C (W229R)\] of *EGFLAM* and rs113710653 \[C/T (E231K)\] of *SPATC1L* were significantly associated with true aortic aneurysm, whereas rs143881017 \[C/T (R140H)\] of *RNASE13* was significantly associated with dissecting aortic aneurysm, in Japanese individuals. The minor alleles of these SNPs were all risk factors for these conditions.

The *EGFLAM* is located at chromosomal region 5p13.2-p13.1 (NCBI Gene, <https://www.ncbi.nlm.nih.gov/gene>) and is expressed in various tissues and organs including vascular smooth muscle (The Human Protein Atlas, <http://www.protein-atlas.org>). EGFLAM is an extracellular matrix-like protein that colocalizes with both dystrophin and dystroglycan to the synaptic cleft of the photoreceptor ribbon synapse in the retina and which directly interacts with dystroglycan. It plays an important role in interactions between the photoreceptor ribbon synapse and bipolar dendrites ([@b20-ijmm-39-05-1091],[@b21-ijmm-39-05-1091]), and it is implicated in defective photoreceptor synaptic function associated with congenital muscular dystrophies such as muscle-eye-brain disease caused by defective glycosylation of α-dystroglycan ([@b22-ijmm-39-05-1091]). A genome-wide pharmacogenomics study identified *EGFLAM* as a potential susceptibility locus for citalopram-induced side effects ([@b23-ijmm-39-05-1091]). We have now shown that rs1465567 \[T/C (W229R)\] of *EGFLAM* was significantly associated with true aortic aneurysm, with the minor C allele representing a risk factor for this condition, although the molecular mechanism underlying this association remains unclear.

The *SPATC1L* is located at chromosomal region 21q22.3 (NCBI Gene) and is expressed in various tissues and organs including vascular smooth muscle (The Human Protein Atlas). SPATC1L is distributed in the cytoplasm, nucleus, and perinuclear region of cells, and it translocates to the sites of cell-cell junctions in response to stimulation of cells with the neuropeptide neurokinin A ([@b24-ijmm-39-05-1091]). Expression of *SPATC1L* was also found to modulate the response of cells to *N*-methyl-*N*′-nitro-*N*-nitrosoguanidine and may thereby protect cells from cell death induced by this DNA-damaging agent ([@b25-ijmm-39-05-1091]). We demonstrated that rs113710653 \[C/T (E231K)\] of *SPATC1L* was significantly associated with true aortic aneurysm, with the minor T allele representing a risk factor for this condition, although the functional relevance of this association remains to be elucidated.

*RNASE13* is located at chromosomal region 14q11.2 (NCBI Gene) and is expressed at a high level in the epididymis (The Human Protein Atlas). A GWAS showed that an SNP (rs3748348) located in the vicinity of *RNASE13* was associated with executive functioning resilience ([@b26-ijmm-39-05-1091]). Gene-based analyses also revealed a genome-wide significant association between *RNASE13* and executive functioning resilience ([@b27-ijmm-39-05-1091]). We now showed that rs143881017 \[C/T (R140H)\] of *RNASE13* was significantly associated with dissecting aortic aneurysm, with the minor T allele representing a risk factor for this condition, although the molecular mechanism underpinning this association remains unknown.

Previous GWASs identified the SNPs: rs10757278 of *CDKN2BAS*, rs7025486 of *DAP2IP*, rs1466535 of *LRP1*, rs2118181 of *FBN1*, rs6511720 of *LDLR* and rs599839 of *SORT1* as susceptibility loci for aortic aneurysm ([@b7-ijmm-39-05-1091]--[@b12-ijmm-39-05-1091]). The MAFs of these SNPs were \>10%, and the odds ratios were 0.8--1.8 (5.7--12.28). We now identified three novel loci that may confer susceptibility to true or dissecting aortic aneurysm, with the odds ratios (MAF, %) of rs1465567 of *EGFLAM*, rs113710653 of *SPATC1L*, and rs143881017 of *RNASE13* being 1.63 (25.1%), 5.32 (1.9%),and 5.77 (0.5%), respectively. Although rs1465567 of *EGFLAM* was a common variant with a small effect size, rs113710653 of *SPATC1L* and rs143881017 of *RNASE13* were low-frequency variants with moderate to large effect sizes.

There are some limitations to the present study: i) Given that the number of subjects with aortic aneurysm was relatively small and the results of the study were not replicated, our findings will require validation with other independent subject panels or in other ethnic groups. ii) It is possible that rs1465567 of *EGFLAM*, rs113710653 of *SPATC1L*, or rs143881017 of *RNASE13* is in linkage disequilibrium with other polymorphisms in the same gene or in other nearby genes that are actually responsible for the development of true or dissecting aneurysm. iii) The functional relevance of these SNPs to the pathogenesis of true or dissecting aneurysm remains to be elucidated.

In conclusion, rs1465567 of *EGFLAM* and rs113710653 of *SPATC1L* may be susceptibility loci for true aortic aneurysm and rs143881017 of *RNASE13* may be such a locus for dissecting aortic aneurysm in Japanese individuals. Determination of genotypes for these SNPs may prove informative for assessment of the genetic risk for these conditions in Japanese individuals.
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###### 

Characteristics of the 8,782 study subjects.

  Characteristics                Aortic aneurysm   Control     P-value
  ------------------------------ ----------------- ----------- ----------
  No. of subjects                456               8326        
  Age (years)                    74.7±13.5         57.3±13.5   \<0.0001
  Gender (male/female, %)        64.0/36.0         51.4/48.6   \<0.0001
  Body mass index (kg/m^2^)      23.2±3.5          23.1±3.5    0.7068
  Current or former smoker (%)   44.1              39.8        0.1777
  Hypertension (%)               94.5              40.7        \<0.0001
  Diabetes mellitus (%)          44.7              14.7        \<0.0001
  Dyslipidemia (%)               67.9              56.8        0.0006
  Chronic kidney disease (%)     41.9              17.5        \<0.0001
  Hyperuricemia (%)              25.7              16.1        0.0003

Quantitative data are expressed as means ± SD and were compared between patients with aortic aneurysm and control individuals with the unpaired Student\'s t-test. Categorical data were compared with Fisher\'s exact test. Based on Bonferroni\'s correction, a P-value of \<0.0056 (0.05/9) was considered statistically significant.

###### 

The 59 single nucleotide polymorphisms (SNPs) significantly (P\<1.21×10^−6^) associated with aortic aneurysm in an exome-wide association study (EWAS).

  Gene             dbSNP         Nucleotide (amino acid) substitution[a](#tfn3-ijmm-39-05-1091){ref-type="table-fn"}   Chromosome: position   MAF (%)   P-value (allele)   Allele OR
  ---------------- ------------- ------------------------------------------------------------------------------------- ---------------------- --------- ------------------ -----------
  *CATSPER4*       rs11247866    A/G (Q77R)                                                                            1:26191303             0.4       9.82×10^−147^      1.81
  *RNASE13*        rs143881017   C/T (R140H)                                                                           14:21033870            0.5       2.49×10^−144^      2.77
  *RNASE10*        rs202109789   G/A (G87S)                                                                            14:20510730            0.2       4.32×10^−123^      0.47
                   rs2582513     A/G                                                                                   14:104948453           39.9      1.72×10^−118^      0.86
  *HEATR1*         rs193150310   T/A (V1975D)                                                                          1:236554752            0.3       3.09×10^−118^      0.76
  *KIAA1217*       rs10828663    G/A (A807T)                                                                           10:24524525            10.4      2.68×10^−100^      1.00
  *MTUS1*          rs3739407     G/A (R148C)                                                                           8:17755366             38.4      2.32×10^−87^       0.98
  *OR5W2*          rs75634103    G/A                                                                                   11:55914523            10.4      2.74×10^−87^       1.11
  *ALPK1*          rs2074379     A/G (I732M)                                                                           4:112431743            32.0      1.03×10^−86^       1.11
  *ATAD5*          rs11657270    T/C (Y1419H)                                                                          17:30887369            18.1      3.24×10^−64^       1.13
  *ACAT2*          rs25683       A/G (K211R)                                                                           6:159775311            18.8      1.90×10^−61^       0.86
  *ZNF474*         rs201335566   G/A (R253Q)                                                                           5:122152748            0.5       4.22×10^−44^       1.29
  *ZNF804B*        rs6963781     A/G (M1105V)                                                                          7:89336295             5.1       1.85×10^−42^       0.90
  *LOC100506679*   rs5751416     G/A                                                                                   22:43036820            26.3      1.62×10^−41^       0.81
  *SSPO*           rs191064068   G/A (R209H)                                                                           7:149777738            1.1       8.55×10^−35^       1.13
  *ARHGEF28*       rs536568      A/C                                                                                   5:73935841             45.8      3.61×10^−33^       1.03
  *TMEM2*          rs142154818   G/A (T1062M)                                                                          9:71700645             1.0       6.41×10^−33^       1.90
  *HLA-DMB*        rs151719      A/G                                                                                   6:32936123             25.7      1.11×10^−30^       1.03
  *CCDC66*         rs61747994    T/C (L802S)                                                                           3:56619399             9.8       3.77×10^−30^       0.92
                   rs3135365     T/G                                                                                   6:32421478             18.9      1.62×10^−28^       0.84
  *NAA25*          rs12231744    C/T (R876K)                                                                           12:112039251           35.1      5.02×10^−28^       1.07
  *RALGAPA2*       rs142962992   G/C (E1676D)                                                                          20:20505435            0.9       1.77×10^−26^       1.10
  *NEU1*           rs13118       T/A                                                                                   6:31859509             9.7       6.92×10^−22^       1.20
  *AXDND1*         rs41267592    C/T (T627M)                                                                           1:179468524            0.3       1.42×10^−20^       0.63
  *PHYKPL*         rs146105181   T/C (N88D)                                                                            5:178230016            0.2       2.15×10^−20^       1.46
  *PCDH8*          rs5030685     A/G (V743A)                                                                           13:52846209            0.3       9.92×10^−20^       2.72
  *SELE*           rs5361        T/G (S149R)                                                                           1:1169731919           3.3       2.49×10^−17^       0.95
  *MOV10L1*        rs760749      A/C (I454L)                                                                           22:50117257            27.8      2.97×10^−17^       1.02
  *HHLA1*          rs75623295    C/G (T90R)                                                                            8:132098893            2.9       1.23×10^−16^       0.80
  *TUBB1*          rs6070697     G/A (R307H)                                                                           20:59024347            12.1      2.17×10^−16^       0.92
  *ZNF708*         rs504280      C/T (R66Q)                                                                            19:21294577            7.4       2.16×10^−15^       0.96
  *TICRR*          rs79501973    G/A (V1373I)                                                                          15:89624427            14.7      2.51×10^−15^       0.97
  *ADNP*           rs148496595   C/G (D924E)                                                                           20:50891942            0.3       2.71×10^−14^       0.68
  *FCAR*           rs11666735    G/A (D113N)                                                                           19:54885501            3.2       3.10×10^−14^       1.03
                   rs2823962     G/A                                                                                   21:16673913            32.8      7.80×10^−14^       0.93
  *EGFLAM*         rs1465567     T/C (W229R)                                                                           5:38370435             25.1      5.92×10^−13^       1.19
                   rs1480347     G/A                                                                                   8:20489946             17.3      3.49×10^−12^       1.07
  *UBE4B*          rs180983516   G/A (R331H)                                                                           1:10106379             0.8       4.50×10^−12^       0.60
                   rs448705      A/G                                                                                   8:17837193             12.4      5.42×10^−12^       1.01
                   rs11970286    C/T                                                                                   6:118359211            17.3      1.38×10^−11^       0.90
                   rs10047727    T/C                                                                                   13:21743051            42.7      6.67×10^−10^       0.90
                   rs507856      C/T                                                                                   3:161736158            38.3      7.71×10^−9^        0.93
  *SLC1A6*         rs7253812     C/A                                                                                   19:14982691            26.7      9.43×10^−9^        0.99
  *FGB*            rs1800789     G/A                                                                                   4:154561591            13.3      1.86×10^−8^        0.99
  *SLC9A4*         rs1014286     A/G (S784G)                                                                           2:102532641            43.9      1.90×10^−8^        1.13
  *HECTD4*         rs2074356     C/T                                                                                   12:112207597           25.4      2.22×10^−8^        1.03
  *PKD1L1*         rs66755489    G/A (P2021L)                                                                          7:47835032             2.9       2.50×10^−8^        1.16
  *CAMSAP1*        rs201291561   T/C (N1062S)                                                                          9:135821476            0.2       3.04×10^−8^        1.14
  *C7orf43*        rs3800952     C/T (R353Q)                                                                           7:100160331            6.3       4.08×10^−8^        1.08
  *ZNF671*         rs3746207     G/A (A149V)                                                                           19:57721640            12.6      5.90×10^−8^        0.99
  *RIN3*           rs7150931     T/C                                                                                   14:92671696            46.2      1.26×10^−7^        1.03
                   rs10805579    G/A                                                                                   5:19127418             10.5      1.48×10^−7^        1.03
                   rs12546220    T/C                                                                                   8:69461493             29.1      1.82×10^−7^        0.96
  *DRD2*           rs12363125    C/T                                                                                   11:113415194           6.2       1.89×10^−7^        0.88
  *MTUS2*          rs17571410    G/A                                                                                   13:29007481            41.4      2.35×10^−7^        0.91
  *GALNTL5*        rs11766982    A/G                                                                                   7:151996417            27.6      2.56×10^−7^        1.05
  *POLE*           rs5745022     C/T                                                                                   12:132632393           20.6      2.82×10^−7^        0.96
  *CHAT*           rs3810947     A/G                                                                                   10:49613197            43.0      3.19×10^−7^        0.97
  *LILRB5*         rs117421142   A/G (I420T)                                                                           19:54252383            1.0       1.16×10^−6^        1.29

Allele frequencies were analyzed with Fisher\'s exact test.

Major allele/minor allele. MAF, minor allele frequency; OR, odds ratio.

###### 

Correlation of single nucleotide polymorphisms (SNPs) to aortic aneurysm as determined by multivariable logistic regression analysis.

  SNP                          Dominant   Recessive           Additive 1   Additive 2                                                
  ------------- -------------- ---------- ------------------- ------------ ------------------- -------- ------------------- -------- --
  rs143881017   C/T (R140H)    0.0208     3.00 (1.20--6.80)   0.9665                           0.0207   3.00 (1.20--6.79)   0.9667   
  rs5751416     G/A            0.0351     0.79 (0.63--0.98)   0.2034                           0.0697                       0.1055   
  rs142154818   G/A (T1062M)   0.0486     1.94 (1.00--3.50)   0.7044                           0.0452   1.97 (1.02--3.54)   0.7078   
  rs13118       T/A            0.0415     1.32 (1.01--1.71)   0.4182                           0.0245   1.37 (1.04--1.78)   0.4879   
  rs5030685     A/G (V743A)    0.0293     2.94 (1.13--6.76)   0.6067                           0.0227   3.12 (1.19--7.22)   0.6090   
  rs1465567     T/C (W229R)    0.0004     1.49 (1.19--1.85)   0.6932                           0.0004   1.51 (1.20--1.90)   0.2807   
  rs7253812     C/A            0.0834                         0.0543                           0.0189   1.31 (1.05--1.65)   0.1650   
  rs7150931     T/C            0.5033                         0.0224       1.36 (1.04--1.75)   0.9225                       0.0586   

Multivariable logistic regression analysis was performed with adjustment for age, gender and the prevalence of hypertension. Based on Bonferroni\'s correction, a P-value of \<2.12×10^−4^ (0.05/236) was considered statistically significant. OR, odds ratio; CI, confidence interval.

###### 

Correlation of single nucleotide polymorphisms (SNPs) to true aortic aneurysm as determined by multivariable logistic regression analysis.

  SNP                          Dominant     Recessive           Additive 1    Additive 2                                               
  ------------- -------------- ------------ ------------------- ------------- -------------- ------------ ------------------- -------- --
  rs143881017   C/T (R140H)    0.2899                           ND                           0.2899                           ND       
  rs5751416     G/A            0.0448       0.73 (0.54--0.99)   0.1221                       0.1030                           0.0663   
  rs142154818   G/A (T1062M)   0.2214                           0.8209                       0.2154                           0.8231   
  rs13118       T/A            0.0253       1.51 (1.05--2.14)   0.6076                       0.0167       1.57 (1.09--2.23)   0.6967   
  rs5030685     A/G (V743A)    0.0779                           0.7314                       0.0667                           0.7333   
  rs1465567     T/C (W229R)    **0.0014**   1.63 (1.21--2.21)   0.6670                       **0.0014**   1.66 (1.22--2.27)   0.2911   
  rs7253812     C/A            0.0122       1.47 (1.09--1.99)   0.2265                       0.0032       1.60 (1.17--2.18)   0.5864   
  rs7150931     T/C            0.7329                           0.0431 1.45   (1.01--2.04)   0.2737                           0.2350   

Multivariable logistic regression analysis was performed with adjustment for age, gender and the prevalence of hypertension. Based on Bonferroni\'s correction, P-values of \<0.0016 (0.05/32) were considered statistically significant and are shown in bold. OR, odds ratio; CI, confidence interval; ND, not determined.

###### 

The 45 single nucleotide polymorphisms (SNPs) significantly (P\<1.21×10^−6^) associated with true aortic aneurysm in an exome-wide association study (EWAS).

  Gene             dbSNP         Nucleotide (amino acid) substitution[a](#tfn7-ijmm-39-05-1091){ref-type="table-fn"}   Chromosome: position   MAF (%)   P-value (allele)   Allele OR
  ---------------- ------------- ------------------------------------------------------------------------------------- ---------------------- --------- ------------------ -----------
  *KIAA1217*       rs10828663    G/A (A807T)                                                                           10:24524525            10.4      6.87×10^−94^       1.14
  *NRAP*           rs79461687    G/T (H1246Q)                                                                          10:113606247           1.3       1.58×10^−90^       1.67
  *OR5W2*          rs75634103    G/A                                                                                   11:55914523            10.4      4.84×10^−81^       1.17
  *ATAD5*          rs11657270    T/C (Y1419H)                                                                          17:30887369            18.1      9.29×10^−70^       0.98
                   rs9683944     A/G                                                                                   4:137512008            10.8      1.65×10^−56^       0.83
  *TMPRSS3*        rs928302      C/T (V53I)                                                                            21:42389975            27.6      1.34×10^−52^       0.99
  *ZNF804B*        rs6963781     A/G (M1105V)                                                                          7:89336295             5.1       6.67×10^−47^       1.01
  *ZNF474*         rs201335566   G/A (R253Q)                                                                           5:122152748            0.5       5.79×10^−42^       0.84
  *LOC100506679*   rs5751416     G/A                                                                                   22:43036820            26.3      2.46×10^−26^       0.71
  *ARHGEF28*       rs536568      A/C                                                                                   5:73935841             45.8      3.10×10^−23^       1.03
  *RALGAPA2*       rs142962992   G/C (E1676D)                                                                          20:20505435            0.9       8.85×10^−23^       0.72
  *LYSMD1*         rs79024247    G/T (Q150K)                                                                           1:151160974            5.2       7.43×10^−21^       0.88
  *CNGA1*          rs192912733   C/T (R493Q)                                                                           4:47937223             0.7       8.13×10^−21^       1.17
  *MOV10L1*        rs760749      A/C (I454L)                                                                           22:50117257            27.8      1.23×10^−20^       1.18
  *HLA-DMB*        rs151719      A/G                                                                                   6:32936123             25.7      1.96×10^−19^       1.17
  *TUBB1*          rs6070697     G/A (R307H)                                                                           20:59024347            12.1      3.20×10^−18^       0.97
                   rs3135365     T/G                                                                                   6:32421478             18.9      3.94×10^−17^       0.83
  *CCDC33*         rs1484214     A/C                                                                                   15:74288732            49.3      6.60×10^−17^       1.09
  *ZNF708*         rs504280      C/T (R66Q)                                                                            19:21294577            7.4       3.03×1^0−15^       0.98
                   rs2823962     G/A                                                                                   21:16673913            32.8      3.36×10^−14^       0.97
  *SGCZ*           rs1037934     G/A                                                                                   8:14399065             9.0       3.44×10^−13^       1.22
  *DUOX1*          rs199549867   A/T (R569S)                                                                           15:45141997            0.2       1.58×10^−10^       0.81
  *CTSC*           rs3888798     T/C (I453V)                                                                           11:88294041            16.5      3.21×10^−10^       1.06
  *C10orf128*      rs118189413   C/G (H67D)                                                                            10:49166908            6.3       4.04×10^−10^       0.84
  *OR5V1*          rs9405124     A/G                                                                                   6:29401036             19.9      4.15×10^−10^       0.98
  *UBAP2L*         rs143080179   T/C (S641P)                                                                           1:154255163            1.3       4.20×10^−10^       0.66
  *CAMSAP1*        rs201291561   T/C (N1062S)                                                                          9:135821476            0.2       5.67×10^−10^       1.87
  *TICRR*          rs79501973    G/A (V1373I)                                                                          15:89624427            14.7      7.76×10^−10^       1.04
  *NCAM1*          rs7111410     C/T                                                                                   11:113178565           15.9      2.63×10^−9^        0.80
  *IRGQ*           rs3817        C/A                                                                                   19:43586043            47.7      3.30×10^−9^        0.92
  *SSPO*           rs191064068   G/A (R209H)                                                                           7:149777738            1.1       2.35×10^−8^        1.67
  *SLC9A4*         rs1014286     A/G (S784G)                                                                           2:102532641            43.9      2.84×10^−8^        1.11
                   rs2138852     A/G                                                                                   17:29376331            2.5       2.92×10^−8^        0.77
  *SPATC1L*        rs113710653   C/T (E231K)                                                                           21:46161921            1.9       3.91×10^−8^        7.39
  *DRD2*           rs12363125    C/T                                                                                   11:113415194           6.2       4.99×10^−8^        0.87
  *CCT5*           rs201280643   C/G (S373C)                                                                           5:10262584             0.4       7.04×10^−8^        0.99
  *AXDND1*         rs41267592    C/T (T627M)                                                                           1:179468524            0.3       7.85×10^−8^        1.03
                   rs507856      C/T                                                                                   3:161736158            38.3      1.10×10^−7^        1.02
                   rs962040      A/G                                                                                   8:15454369             30.1      1.21×10^−7^        0.96
                   rs11970286    C/T                                                                                   6:118359211            17.3      1.60×10^−7^        0.83
  *NINL*           rs199671123   C/T (A796T)                                                                           20:25476905            0.2       2.45×10^−7^        0.85
                   rs12531488    C/T                                                                                   7:145194993            16.0      7.91×10^−7^        1.14
  *MROH7*          rs143029488   G/C (A1313P)                                                                          1:54710152             0.8       1.05×10^−6^        1.34
  *AFAP1*          rs28406288    G/C (C403S)                                                                           4:7800500              0.1       1.10×10^−6^        ND
  *GALM*           rs6741892     A/T (N190Y)                                                                           2:38689828             20.1      1.12×10^−6^        0.93

Allele frequencies were analyzed with Fisher\'s exact test.

Major allele/minor allele. MAF, minor allele frequency; OR, odds ratio; ND, not determined.

###### 

The 19 single nucleotide polymorphisms (SNPs) significantly (P\<1.21×10^−6^) associated with dissecting aortic aneurysm in an exome-wide association study (EWAS).

  Gene         dbSNP         Nucleotide (amino acid) substitution[a](#tfn9-ijmm-39-05-1091){ref-type="table-fn"}   Chromosome: position   MAF (%)   P-value (allele)   OR
  ------------ ------------- ------------------------------------------------------------------------------------- ---------------------- --------- ------------------ ------
  *ATXN7*      rs3774729     G/A (V862M)                                                                           3:63996406             46.8      3.81×10^−35^       0.91
  *KIAA1217*   rs10828663    G/A (A807T)                                                                           10:24524525            10.4      1.34×10^−27^       0.78
  *RNASE13*    rs143881017   C/T (R140H)                                                                           14:21033870            0.5       5.12×10^−26^       4.48
  *INPP5F*     rs3736822     A/G (I453V)                                                                           10:119806397           1.7       8.50×10^−23^       0.62
               rs9683944     A/G                                                                                   4:137512008            10.8      4.61×10^−17^       1.17
               rs9610342     A/G                                                                                   22:35734530            30.7      8.20×10^−17^       0.79
  *FAM98C*     rs3745962     C/A (T240K)                                                                           19:38405604            16.7      8.99×10^−15^       0.96
  *ZNF474*     rs201335566   G/A (R253Q)                                                                           5:122152748            0.5       1.02×10^−12^       1.95
               rs3135365     T/G                                                                                   6:32421478             18.9      1.21×10^−12^       0.86
  *DEPDC7*     rs34161108    G/A (A192T)                                                                           11:33027795            6.2       2.29×10^−12^       0.74
  *ARHGEF28*   rs536568      A/C                                                                                   5:73935841             45.8      5.53×10^−12^       1.04
  *RALGPS1*    rs57728614    G/T (G383C)                                                                           9:127196583            9.5       5.73×10^−11^       0.84
  *AIM1L*      rs34370465    C/T (R847H)                                                                           1:26344118             23.9      3.63×10^−10^       1.09
  *ANXA7*      rs3750575     C/T (R419Q)                                                                           10:73378933            5.7       4.20×10^−10^       1.06
  *AXDND1*     rs41267592    C/T (T627M)                                                                           1:179468524            0.3       1.77×10^−8^        ND
               rs2138852     A/G                                                                                   17:29376331            2.5       1.49×10^−7^        1.32
  *CHAT*       rs78925077    C/G (S119R)                                                                           10:49622109            0.5       1.50×10^−7^        1.93
  *GPR156*     rs902790      A/T (E512D)                                                                           3:120167929            4.8       2.24×10^−7^        0.71
  *SELE*       rs5361        T/G (S149R)                                                                           1:169731919            3.3       3.58×10^−7^        0.98

Allele frequencies were analyzed with Fisher\'s exact test.

Major allele/minor allele. MAF, minor allele frequency; OR, odds ratio; ND, not determined.

###### 

Relation of single nucleotide polymorphisms (SNPs) to true or dissecting aortic aneurysm as determined by multivariable logistic regression analysis.

  ---------------------------------------------------------------------------------------------------------------------------------------
  SNP                           Dominant     Recessive            Additive 1   Additive 2                                              
  ----------------------------- ------------ -------------------- ------------ ------------ ------------ -------------------- -------- --
  True aortic aneurysm\         **0.0002**   5.32 (2.33--11.14)   0.9263                    **0.0002**   5.34 (2.34--11.18)   0.9299   
  rs113710653 C/T (E231K)                                                                                                              

  Dissecting aortic aneurysm\   **0.0006**   5.77 (2.25--12.95)   0.9615                    **0.0006**   5.48 (2.26--12.97)   0.9621   
  rs143881017 C/T (R140H)                                                                                                              
  ---------------------------------------------------------------------------------------------------------------------------------------

Multivariable logistic regression analysis was performed with adjustment for age, gender and the prevalence of hypertension. Based on Bonferroni\'s correction, P-values of \<2.78×10^−4^ (0.05/180) or \<6.58×10^−4^ (0.05/76) were considered statistically significant for true or dissecting aortic aneurysm, respectively, and are shown in bold. OR, odds ratio; CI, confidence interval.
